Roflumilast
Brand name: Roflumilast
Rank #398 of 500 drugs by total cost
$22.8M
Total Cost
97,022
Total Claims
$22.8M
Total Cost
3,651
Prescribers
$235
Cost per Claim
8,902
Beneficiaries
134,918
30-Day Fills
$6,255
Avg Cost/Provider
27
Avg Claims/Provider
About Roflumilast
Roflumilast (sold as Roflumilast) was prescribed 97,022 times by 3,651 Medicare Part D providers in 2023, costing the program $22.8M. At $235 per claim, this is a moderately priced medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 395 | Droxidopa (Droxidopa) | $23.4M | 9,058 |
| 396 | Fenofibrate Nanocrystallized (Fenofibrate) | $23.2M | 602,181 |
| 397 | Ravulizumab-Cwvz (Ultomiris) | $23.1M | 428 |
| 398 | Roflumilast (Roflumilast) | $22.8M | 97,022 |
| 399 | Romosozumab-Aqqg (Evenity (2 Syringes)) | $22.3M | 9,087 |
| 400 | Azithromycin (Azithromycin) | $22.2M | 3,009,458 |
| 401 | Torsemide (Torsemide) | $22.2M | 971,579 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology